Cryptococcal transmigration across a model brain blood-barrier: Evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265

Microbes and Infection

Volumn 18, Issue 1, 2016, Pages 57-67

  Sorrell, Tania C ^a   Juillard, Pierre Georges ^a,c   Djordjevic, Julianne T ^a   Kaufman Francis, Keren ^a   Dietmann, Anelia ^b,c   Milonig, Alban ^b,c   Combes, Valery ^a,c   Grau, Georges E R ^a,c  

^a WESTMEAD HOSPITAL   (Australia)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Brain endothelium; Cryptococcus; Monocytes; Phagocytosis; Transmigration

Indexed keywords

GAMMA INTERFERON; TUMOR NECROSIS FACTOR;

ARTICLE; BINDING AFFINITY; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; CELL STIMULATION; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS GRUBII; CRYPTOCOCCUS NEOFORMANS; FILOBASIDIELLA; FUNGAL STRAIN; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SHEAR STRESS; BIOLOGICAL MODEL; CELL CULTURE; CELL MOTION; ENDOTHELIUM CELL; MICROBIOLOGY; PHYSIOLOGY;

BLOOD-BRAIN BARRIER; CELL MOVEMENT; CELLS, CULTURED; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MODELS, BIOLOGICAL;

EID: 84953835392     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2015.08.017     Document Type: Article

References (29)

1. Galanis E., Hoang L., Kibsey P., Morshed M., Phillips P. Clinical presentation, diagnosis and management of Cryptococcus gattii cases: lessons learned from British Columbia. Can J Infect Dis Med Microbiol 2009, 20:23-28.
2. Chen S., Sorrell T., Nimmo G., Speed B., Currie B., Ellis D., et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis 2000, 31:499-508.
3. Krockenberger M.B., Malik R., Ngamskulrungroj P., Trilles L., Escandon P., Dowd S., et al. Pathogenesis of pulmonary Cryptococcus gattii infection: a rat model. Mycopathologia 2010, 170:315-330.
4. Ngamskulrungroj P., Chang Y., Sionov E., Kwon-Chung K.J. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model. MBio 2012, 3:e00103-e00112.
5. Charlier C., Chretien F., Baudrimont M., Mordelet E., Lortholary O., Dromer F. Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol 2005, 166:421-432.
6. Olszewski M.A., Noverr M.C., Chen G.H., Toews G.B., Cox G.M., Perfect J.R., et al. Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol 2004, 164:1761-1771.
7. Jong A., Wu C.H., Gonzales-Gomez I., Kwon-Chung K.J., Chang Y.C., Tseng H.K., et al. Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection. J Biol Chem 2012, 287:15298-15306.
8. Jong A., Wu C.H., Shackleford G.M., Kwon-Chung K.J., Chang Y.C., Ouyang Y., et al. Involvement of human CD44 during Cryptococcus neoformans infection of brain microvascular endothelial cells. Cell Microbiol 2008, 10:1313-1326.
9. Shi M., Li S.S., Zheng C., Jones G.J., Kim K.S., Zhou H., et al. Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. J Clin Invest 2010, 120:1683-1693.
10. Singh A., Panting R.J., Varma A., Saijo T., Waldron K.J., Jong A., et al. Factors required for activation of urease as a virulence determinant in Cryptococcus neoformans. MBio 2013, 4. e00220-13.
11. Santangelo R., Zoellner H., Sorrell T., Wilson C., Donald C., Djordjevic J., et al. Role of extracellular phospholipases and mononuclear phagocytes in dissemination of cryptococcosis in a murine model. Infect Immun 2004, 72:2229-2239.
12. Charlier C., Nielsen K., Daou S., Brigitte M., Chretien F., Dromer F. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun 2009, 77:120-127.
13. Wang H., Sun J., Goldstein H. Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide. J Virol 2008, 82:7591-7600.
14. Ma H., Croudace J.E., Lammas D.A., May R.C. Expulsion of live pathogenic yeast by macrophages. Curr Biol 2006, 16:2156-2160.
15. Alvarez M., Casadevall A. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr Biol 2006, 16:2161-2165.
16. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
17. Wen B., Combes V., Bonhoure A., Weksler B.B., Couraud P.O., Grau G.E. Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses. PLoS One 2014, 9:e91597.
18. MacDougall D.S. A dearth of groundbreaking data at 14th international conclave of HIV medical community. IAPAC Mon 2002, 8:276-282.
19. Ngamskulrungroj P., Price J., Sorrell T., Perfect J.R., Meyer W. Cryptococcus gattii virulence composite: candidate genes revealed by microarray analysis of high and less virulent Vancouver island outbreak strains. PLoS One 2011, 6:e16076.
20. Cheng P.Y., Sham A., Kronstad J.W. Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Infect Immun 2009, 77:4284-4294.
21. Zhou Q., Murphy W.J. Immune response and immunotherapy to Cryptococcus infections. Immunol Res 2006, 35:191-208.
22. Grau G.E., Lou J. TNF in vascular pathology: the importance of platelet-endothelium interactions. Res Immunol 1993, 144:355-363.
23. Pober J.S. Immunobiology of human vascular endothelium. Immunol Res 1999, 19:225-232.
24. Ronald J.A., Ionescu C.V., Rogers K.A., Sandig M. Differential regulation of transendothelial migration of THP-1 cells by ICAM-1/LFA-1 and VCAM-1/VLA-4. J Leukoc Biol 2001, 70:601-609.
25. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 2007, 7:678-689.
26. Licona-Limon I., Garay-Canales C.A., Munoz-Paleta O., Ortega E. CD13 mediates phagocytosis in human monocytic cells. J Leukoc Biol 2015, 98:85-98.
27. Gabrilovac J., Cupic B., Zivkovic E., Horvat L., Majhen D. Expression, regulation and functional activities of aminopeptidase N (EC 3.4.11.2; APN; CD13) on murine macrophage J774 cell line. Immunobiology 2011, 216:132-144.
28. Maruvada R., Zhu L., Pearce D., Zheng Y., Perfect J., Kwon-Chung K.J., et al. Cryptococcus neoformans phospholipase B1 activates host cell Rac1 for traversal across the blood-brain barrier. Cell Microbiol 2012, 14:1544-1553.
29. Voelz K., Lammas D.A., May R.C. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun 2009, 77:3450-3457.